Magle Chemoswed
31 SEK +2.65%Be the first to follow this company
Magle Chemoswed operates in the pharmaceutical industry. The company specializes in the development of analytical programs. The product portfolio is broad and includes, for example, programs for internal follow-up, process, and system management. In addition to the main business, service and associated ancillary services are also offered within the work area. The business is run worldwide with the largest presence in the Nordic market. Magle Chemoswed is headquartered in Malmö.
Revenue
170.44M
EBIT %
10.57 %
P/E
27.43
Dividend yield-%
1.13 %
Target price
-
Recommendation
-
Updated
-
First North Stockholm
MAGLE
Daily low / high price
30.6 / 31.4
SEK
Market cap
334.8M SEK
Turnover
31.49K SEK
Volume
1K
Financial calendar
General meeting
2024-04-25
Interim report
2024-07-18
Interim report
2024-10-24
Annual report
2025-02-26
General meeting
2025-04-25
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Hans Henrik Lidgard (via bolag) | 74.0 % | 74.0 % |
Familjen Eklund | 10.6 % | 10.6 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Magle Chemoswed Holding Reports Financial Results For First Quarter 2024
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools